Quantification of Abdominal Organ Motion Using MRI
NCT04748094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23
Last updated 2025-08-27
Summary
The primary aim of the study is to quantify abdominal motion in order to optimise MR imaging. The study will compare three-motion management strategies a) free-breathing, b) using an abdominal compression belt and c) using MRI-compatible visually guided breath-holds.
Conditions
Interventions
- DEVICE
-
Compression belt
The abdominal belt is fastened around the lower abdomen and inflated (like an inner tube) to apply pressure to the belly and reduce the motion associated with respiration (breathing)
- OTHER
-
Visual Guided Breath-hold
A small tracer will be place on the lower abdomen that will feedback to a computer screen that will have graphics to show you if the participant is in breath-hold or not.
Sponsors & Collaborators
-
The Christie NHS Foundation Trust
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-21
- Primary Completion
- 2023-03-15
- Completion
- 2023-03-15
Countries
- United Kingdom
Study Locations
More Related Trials
-
Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer
NCT05314400 ·Status: RECRUITING ·Phase: NA
-
Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study
NCT05202015 ·Status: UNKNOWN
-
Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
NCT00946140 ·Status: COMPLETED
-
Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies
NCT04332419 ·Status: COMPLETED ·Phase: NA
-
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
NCT01892540 ·Status: COMPLETED ·Phase: NA
-
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
NCT02156739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Molecular Imaging and Spectroscopy With Stable Isotopes in Oncology and Neurology
NCT03526809 ·Status: UNKNOWN
-
Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.
NCT07306975 ·Status: NOT_YET_RECRUITING
-
Advanced Imaging for Pulmonary Fibrosis
NCT06532071 ·Status: RECRUITING ·Phase: PHASE2
-
Single Breath Hold Abdominal MRI
NCT02434471 ·Status: COMPLETED ·Phase: NA
-
68Ga-MY6349 PET/CT in Solid Tumors
NCT07046702 ·Status: RECRUITING
-
Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging
NCT02792959 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions
NCT00527891 ·Status: COMPLETED
-
Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer
NCT04778345 ·Status: UNKNOWN ·Phase: NA
-
7T MRI Scan for the Early Detection of Melanoma Brain Metastases
NCT04941430 ·Status: TERMINATED ·Phase: NA
-
TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors
NCT01747096 ·Status: COMPLETED ·Phase: NA
-
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
NCT00592462 ·Status: COMPLETED
-
4D-MRI for Precision Medicine
NCT04657042 ·Status: RECRUITING
-
Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
NCT03423407 ·Status: TERMINATED
-
Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer
NCT04941872 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
NCT07301814 ·Status: RECRUITING
-
Characterization of Brain Metastases
NCT00184275 ·Status: COMPLETED
-
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
NCT02422550 ·Status: RECRUITING
-
Comparison of the Diagnostic Accuracy of 3D Volume Acquisition MRI With CT in Staging Colonic Cancer
NCT01187641 ·Status: COMPLETED
-
Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung
NCT01741597 ·Status: WITHDRAWN ·Phase: PHASE1